Showing 1,781 - 1,800 results of 1,921 for search '"Texas"', query time: 0.08s Refine Results
  1. 1781
  2. 1782
  3. 1783
  4. 1784
  5. 1785
  6. 1786
  7. 1787

    Design and simulation of a 5 KW solar-powered hybrid electric vehicle charging station with a ANN–Kalman filter MPPT and MPC-based inverter control for reduced THD by Youness Hakam, Hajar Ahessab, Ahmed Gaga, Mohamed Tabaa, Benachir El Hadadi

    Published 2025-03-01
    “…The system achieves a Total Harmonic Distortion (THD) of just 0.56%, boosting charging speed while minimizing harmonic distortion costs. Controlled by Texas Instruments’ TMS320F28379D digital signal processor, this system offers stable, low-cost EV charging by prioritizing solar energy use, even under harsh weather conditions, over reliance on grid power.…”
    Get full text
    Article
  8. 1788
  9. 1789
  10. 1790
  11. 1791
  12. 1792
  13. 1793
  14. 1794

    Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States by Finn RS, Iyer R, Kalman RS, Parikh ND, Cabrera R, Babajanyan S, Kaseb AO

    Published 2025-02-01
    “…Richard S Finn,1 Renuka Iyer,2 Richard S Kalman,3 Neehar D Parikh,4 Roniel Cabrera,5 Svetlana Babajanyan,6 Ahmed O Kaseb7 1Department of Medicine, University of California, Los Angeles, CA, USA; 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA; 3Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA; 4Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA; 5Department of Medicine, University of Florida Health, Gainesville, FL, USA; 6US Medical Affairs, Oncology, Bayer Healthcare, Whippany, NJ, USA; 7Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Richard S Finn, Department of Medicine, University of California, Los Angeles, CA, USA, Tel +1-310-586-2091, Email rfinn@mednet.ucla.eduIntroduction: While several systemic therapies are available for unresectable hepatocellular carcinoma (uHCC), there is a lack of granular real-world evidence to support the efficacy and safety of these therapies. …”
    Get full text
    Article
  15. 1795
  16. 1796
  17. 1797
  18. 1798
  19. 1799

    The association of origin and environmental conditions with performance in professional IRONMAN triathletes by Beat Knechtle, Mabliny Thuany, David Valero, Elias Villiger, Pantelis T. Nikolaidis, Marilia S. Andrade, Ivan Cuk, Thomas Rosemann, Katja Weiss

    Published 2025-01-01
    “…Most of the athletes competed in IRONMAN Hawaii (925), IRONMAN Florida (563), IRONMAN Austria (452), IRONMAN France (354), IRONMAN Wisconsin (330), IRONMAN Lanzarote (322) and IRONMAN Texas (313). The Decision Tree and the XG Boost models were the best performing models (r2 = 0.48) and rated the relative feature importances in the order gender, country of origin, water temperature, air temperature and event location. …”
    Get full text
    Article
  20. 1800